Chinese AI is not just DeepSeek. Nearly half of the world’s top AI researchers come from China, and only 18% come from the United States. China owns 65% of the world’s artificial intelligence patents.
Category: New technology
DeepSeek routed the global AI and stock
DeepSeek’s independently developed MLA architecture and DeepSeek MOE architecture have played a key role in reducing its model training costs.
Quantum computing update, the performance of related stocks
Quantum computing is suitable for solving ‘small data, big calculation’ problems, but they are not good at dealing with problems that require large amounts of data
AI Agent will be the next wave of software industry
AI Agent is a program that can perform long-term tasks with little need for human supervision during the execution of the task
Humanoid Robots current status and vendors
Humanoid robots will usher in explosive maturity in the next five to ten years. It is estimated that by 2035, it will create an output value of nearly US$26 billion.
18 future industry trend and three industries driving billionaire wealth
McKinsey released a report titled “The next big arenas of competetion.” The report points out that from now to 2040, there are a total of “18 future industry trend areas”
Apple repurchase, Buffett sold most of Apple stake,Nvidia capital operation, Tesla, AI bubble, Willow quantum chip, this blog turns off comments
Peter read my post of Apple repurchase two days ago, inspired to write me a letter, raised several great questions and his concerns, I wrap up the feedback to him as this post.
Google’s Willow chip rally related quantum computing stocks. Is it justified?
Google says Willow can “exponentially” reduce errors as the number of quantum bits increases, which “addresses a key challenge in quantum error correction that has been pursued in the field for nearly 30 years.”
How does rising biotech Vertex make money?
Vertex mainly researches and produces various small molecule drugs for the treatment of terminal diseases. Its famous products include Casgevy, the world’s first gene editing therapy, Suzetrigine, a new three-effect cystic fibrosis therapy, Ivacaftor, and anti-hepatitis C drugs. Telaprevir, etc.
How does CRISPR, the gene editing inventor, make money?
CRISPR is a biotech company headquartered in Switzerland. Founded in 2013 by Emmanuelle Charpentier, Shaun Foy and Rodger Novak. It is the first biotechnology company to use CRISPR gene editing and received world first approved.